.Pharmacolibrary.Drugs.C_CardiovascularSystem.C09D_AngiotensinIiReceptorBlockersArbsCombinations.C09DX07_IrbesartanAmlodipineAndHydrochlo.IrbesartanAmlodipineAndHydrochlo .Pharmacolibrary.Drugs.C_CardiovascularSystem.C09D_AngiotensinIiReceptorBlockersArbsCombinations.C09DX07_IrbesartanAmlodipineAndHydrochlo.IrbesartanAmlodipineAndHydrochlo| name: | IrbesartanAmlodipineAndHydrochlorothiazide |
| ATC code: | C09DX07 |
| route: | oral |
| n-compartments | 1 |
Fixed combination tablet of irbesartan (an angiotensin II receptor blocker), amlodipine (a calcium channel blocker), and hydrochlorothiazide (a thiazide diuretic) used for the treatment of essential hypertension in adults; currently approved and used in clinical practice when multi-drug therapy is indicated.
Estimated composite pharmacokinetic parameters for healthy adult subjects, based on published data of individual components. No direct study of triple-combination PK model found.